SEC Comment Letter for Sanofi (SNY, SNYNF) (CIK 0001121404) (SNY) — Jan 27, 2020

Sanofi (SNY, SNYNF) (CIK 0001121404)
Date: Jan. 27, 2020 · CIK: 0001121404 · Accession: 0000000000-20-000685

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-31368

Date

January 27, 2020

Author

Not clearly detected

Form

UPLOAD

Company

Sanofi (SNY, SNYNF) (CIK 0001121404)

Letter

January 27, 2020 Paul Hudson Chief Executive Officer Sanofi 54, Rue La Boétie 75008 Paris France Re:Sanofi Form 20-F for the Fiscal Year Ended December 31, 2018 Filed March 8, 2019 File No. 001-31368 Dear Mr. Hudson: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

January 27, 2020
Paul Hudson
Chief Executive Officer
Sanofi
54, Rue La Boétie
75008 Paris France
Re:Sanofi
Form 20-F for the Fiscal Year Ended December 31, 2018
Filed March 8, 2019
File No. 001-31368
Dear Mr. Hudson:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io